LISSSD 2025 Michael Houghton
Applied Pharmaceutical Innovation, AB, Canada
Presentations this author is a contributor to:
Phase I Trial of a Peptide-based Vaccine to Prevent Group A Streptococcal Infection (118111)
9:15 AM
Michael F. Good
Plenary 5 - Interventions for Prevention
Human antibodies to M-protein epitope-based vaccines demonstrate binding to Streptococcus pyogenes (StrepA) and bactericidal activity (#290)
5:30 PM
Christie T M Short
Poster Session 2